LATEST

• BUSINESS Shionogi Nets 4th Straight Year of Record Earnings on Torii Deal, HIV Royalties
  May 13, 2026

• BUSINESS Santen’s Eylea Sales Fall 15.9% amid Re-Pricing, Biosimilar Entry
  May 13, 2026

• BUSINESS Fuji’s Eylea Biosimilar Logs 776 Million Yen in First 3 Months
  May 13, 2026

• BUSINESS Japan Ethical Drug Sales Climb 9.3% in March: Crecon
  May 13, 2026

• REGULATORY LDP Lawmakers’ League Eyes Broader Push for Domestic API Production
  May 13, 2026

• BUSINESS Daiichi Targets 3 Trillion Yen Sales by FY2030, Global Top-5 Oncology Spot
  May 12, 2026

• BUSINESS Lilly Japan Hits Record Sales as Mounjaro Tops 100 Billion Yen
  May 12, 2026

• REGULATORY AstraZeneca’s Oral SERD, MSD RSV Antibody Up for Japan Panel Review on May 25
  May 12, 2026

• BUSINESS Ferring Nabs Japan Approval for Bladder Cancer Gene Therapy
  May 12, 2026

• BUSINESS Teijin to Offload Legacy Drug Portfolio as It Speeds Up Pivot to Rare Diseases
  May 12, 2026

• BUSINESS Keytruda Extends Run as Japan’s Best-Selling Drug in April: Encise
  May 12, 2026

• BUSINESS ASKA Taps Ex-AbbVie Japan Chief Feliciano as Outside Director
  May 12, 2026

• REGULATORY Daiichi Sankyo Wins Japan Approval for MMR Vaccine Mimrit
  May 12, 2026

• ACADEMIA Arava Safety Backup at Risk as Questran Supply Falters on Nitrosamine Issue
  May 11, 2026

• BUSINESS Daiichi Sankyo Cuts FY2025 Profit Outlook on ADC Supply Plan Review
  May 11, 2026

• BUSINESS Capricor Sues Nippon Shinyaku over US Rights to DMD Cell Therapy
  May 11, 2026

• BUSINESS FDA Delays Review of Leqembi Iqlik for Alzheimer’s Initiation Therapy
  May 11, 2026

• BUSINESS Kyorin, Susmed Start Pivotal Trial of Tinnitus Therapy App
  May 11, 2026

• BUSINESS Kyorin Begins Japan PIII Trial of Beova in Pediatric OAB
  May 11, 2026

• BUSINESS Kyowa Kirin Keeps Long-Term KPIs despite OX40 Setback, Ups 2026 Core Profit Outlook
  May 11, 2026

ページ

• « 先頭
• ‹ Prev
• …
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• Next ›
• 最終 »